Table 2.
LS Mean ± SEM |
P |
|||||
---|---|---|---|---|---|---|
EXE | EXE+ROSI | ROSI | P value EXE vs. EXE+ROSI | P value EXE vs. ROSI | P value EXE+ROSI vs. ROSI | |
Meal challenge | ||||||
n | 33 | 34 | 34 | |||
Glucose AUC (mmol-min/l) | ||||||
Baseline | 1,783 ± 60 | 1,800 ± 60 | 1,742 ± 60 | |||
End point | 1,215 ± 51* | 1,140 ± 50* | 1,349 ± 51* | |||
Change | −560 ± 51 | −635 ± 50 | −426 ± 51 | 0.296 | 0.065 | 0.004 |
Insulin AUC (μIU-min/ml) | ||||||
Baseline | 6,116 ± 723 | 5,203 ± 712 | 6,797 ± 734 | |||
End point | 5,024 ± 339* | 4,152 ± 336* | 4,050 ± 346* | |||
Change | −999 ± 339 | −1,871 ± 336 | −1,973 ± 346 | 0.071 | 0.047 | 0.833 |
C-peptide AUC (nmol-min/l) | ||||||
Baseline | 333 ± 18 | 330 ± 18 | 342 ± 18 | |||
End point | 310 ± 13 | 277 ± 13* | 282 ± 13* | |||
Change | −24 ± 13 | −58 ± 13 | −53 ± 13 | 0.067 | 0.118 | 0.805 |
I/G Index (AUC) (μIU-min/ml)/(mmol-min/l) | ||||||
Baseline | 3.64 ± 0.48 | 3.05 ± 0.47 | 4.10 ± 0.48 | |||
20 weeks | 4.41 ± 0.27* | 3.61 ± 0.27 | 3.06 ± 0.28 | |||
Change | 0.82 ± 0.27 | 0.03 ± 0.27 | −0.53 ± 0.28 | 0.041 | 0.001 | 0.160 |
Matsuda index | ||||||
Baseline | 4.0 ± 0.6 | 4.4 ± 0.6 | 3.4 ± 0.6 | |||
20 weeks | 5.6 ± 0.8* | 8.4 ± 0.8* | 7.1 ± 0.8* | |||
Change | 1.6 ± 0.8 | 4.4 ± 0.8 | 3.1 ± 0.8 | 0.015 | 0.205 | 0.258 |
I/G (AUC) × Matsuda | ||||||
Baseline | 10.8 ± 1.0 | 8.8 ± 1.0 | 10.9 ± 1.0 | |||
20 weeks | 17.1 ± 1.4* | 20.4 ± 1.4* | 18.4 ± 1.5* | |||
Change | 7.0 ± 1.4 | 10.3 ± 1.4 | 8.2 ± 1.5 | 0.111 | 0.550 | 0.325 |
Hyperglycemic Clamp (μIU-min/ml) | ||||||
n | 16 | 18 | 16 | |||
ASI-iAUC | ||||||
Baseline | 643 ± 107 | 686 ± 104 | 786 ± 114 | |||
20 weeks | 1,449 ± 187* | 896 ± 182 | 602 ± 200 | |||
Change | 747 ± 187 | 195 ± 182 | −100 ± 200 | 0.039 | 0.004 | 0.282 |
1st phase iAUC (0–10 min) | ||||||
Baseline | 6 ± 14 | −10 ± 14 | 23 ± 15 | |||
20 weeks | 105 ± 24* | 59 ± 24* | 17 ± 26 | |||
Change | 99 ± 24 | 54 ± 25 | 12 ± 26 | 0.195 | 0.018 | 0.252 |
2nd phase iAUC (10–70 min) | ||||||
Baseline | 937 ± 291 | 740 ± 282 | 1,125 ± 309 | |||
20 weeks | 5,436 ± 833* | 3,422 ± 813* | 487 ± 891 | |||
Change | 4,513 ± 833 | 2,500 ± 813 | −435 ± 891 | 0.09 | <0.001 | 0.019 |
1st and 2nd phase iAUC (0–70 min) | ||||||
Baseline | 955 ± 306 | 742 ± 297 | 1,162 ± 326 | |||
20 weeks | 5,611 ± 862* | 3,527 ± 842* | 503 ± 922 | |||
Change | 4,671 ± 862 | 2,587 ± 842 | −437 ± 922 | 0.09 | <0.001 | 0.02 |
Data are LS means ± SEM.
*P <0.05 from baseline. Matsuda Index = , where FPG and FPI = fasting plasma glucose and insulin and G̅ = average glucose during the meal challenge.